Evidence map›Paper›PMID 27553711›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2016

Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM/TSP outcome.

Fernanda Khouri Barreto, Ricardo Khouri, Filipe Ferreira de Almeida Rego, Luciane Amorim Santos, Maria Fernanda de Castro-Amarante, Izabela Bialuk, Cynthia A Pise-Masison, Bernardo Galvão-Castro, Antoine Gessain, Steven Jacobson and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Complete Rescue of HTLV-1Pathogens (Basel, Switzerland) · 2024
    Article
  4. Mcl-1 Protein and Viral Infections: A Narrative Review.International journal of molecular sciences · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Fernanda Khouri BarretoCentro de Pesquisa Gonçalo Moniz-Fiocruz, Laboratório de Hematologia Genética e Biologia Computacional, Salvador, Bahia, Brazil.
Ricardo KhouriKU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium.
Filipe Ferreira de Almeida RegoCentro de Pesquisa Gonçalo Moniz-Fiocruz, Laboratório de Hematologia Genética e Biologia Computacional, Salvador, Bahia, Brazil.
Luciane Amorim SantosCentro de Pesquisa Gonçalo Moniz-Fiocruz, Laboratório de Hematologia Genética e Biologia Computacional, Salvador, Bahia, Brazil.
Maria Fernanda de Castro-AmaranteAnimal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, USA.
Izabela BialukDepartment of General and Experimental Pathology, Medical University in Białystok, Poland.
Cynthia A Pise-MasisonAnimal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, USA.
Bernardo Galvão-CastroCentro de Pesquisa Gonçalo Moniz-Fiocruz, Laboratório de Hematologia Genética e Biologia Computacional, Salvador, Bahia, Brazil; Escola Bahiana de Medicina e Saúde Publica, Salvador, Bahia, Brazil.
Antoine GessainUnité d'Epidémiologie et Physiopathologie des Virus Oncogènes, Département de Virologie, Batiment Lwoff, Institut Pasteur, Paris, France.
Steven JacobsonViral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, USA.
Genoveffa FranchiniAnimal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, USA.
Luiz Carlos AlcantaraCentro de Pesquisa Gonçalo Moniz-Fiocruz, Laboratório de Hematologia Genética e Biologia Computacional, Salvador, Bahia, Brazil. Electronic address: lalcan@bahia.fiocruz.br.
Fundação Oswaldo Cruz · BRNational Cancer Institute · USInstitut Pasteur · FRKU Leuven · BEMedical University of Białystok · PLNational Institute of Neurological Disorders and Stroke · US

Funding

Involvement Of Human Viruses Associated With Chronic Neurologic DiseaseZIANS002817 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI JACOBSON, STEVEN · 2009 to 2025
$26.5M
Translational studies of human viruses and chronic neurologic diseaseZIANS003040 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI JACOBSON, STEVEN · 2009 to 2025
$10.1M
Retrovirus Associated With Chronic Neurologic DiseaseZ01NS002817 · NINDS · NEUROLOGICAL DISORDERS AND STROKE · PI JACOBSON, STEVEN · 1990 to 2008
$4.0M
Translational studies of human viruses and chronic neurologic disesaeZ01NS003040 · NINDS · NEUROLOGICAL DISORDERS AND STROKE · PI JACOBSON, STEVEN · 2007 to 2008
$1.7M
Intramural NIH HHS Z01 NS002817Intramural NIH HHS Z01 NS003040
6 · The paper itself

Abstract

The region known as pX in the 3' end of the human T-cell lymphotropic virus type 1 (HTLV-1) genome contains four overlapping open reading frames (ORF) that encode regulatory proteins. HTLV-1 ORF-I produces the protein p12 and its cleavage product p8. The functions of these proteins have been linked to immune evasion and viral infectivity and persistence. It is known that the HTLV-1 infection does not necessarily imply the development of pathological processes and here we evaluated whether natural mutations in HTLV-1 ORF-I can influence the proviral load and clinical manifestation of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). For that, we performed molecular characterization, datamining and phylogenetic analysis with HTLV-1 ORF-I sequences from 156 patients with negative or positive diagnosis for HAM/TSP. Our analyses demonstrated that some mutations may be associated with the outcome of HAM/TSP (C39R, L40F, P45L, S69G and R88K) or with proviral load (P34L and F61L). We further examined the presence of mutations in motifs of HBZ and observed that P45L mutation is located within the HBZ nuclear localization signal and was found more frequently between patients with HAM/TSP and high proviral load. These results indicate that some natural mutations are located in functional domains of ORF-I and suggests a potential association between these mutations and the proviral loads and development of HAM/TSP. Therefore it is necessary to conduct functional studies aimed at evaluating the impact of these mutations on the virus persistence and immune evasion.

Indexed as

HumansHuman T-lymphotropic virus 1Molecular EpidemiologyMutationOpen Reading FramesParaparesis, Tropical SpasticRNA, ViralViral LoadRNA, ViralHAM/TSPHTLV-1ORF-1

Identifiers

PMID27553711
PMCPMC5123959
OpenAlexW2518222340

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.